Anna Kwilas
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Virus-based gene therapy research, CAR-T cell therapy research, Prostate Cancer Treatment and Research
Most-Cited Works
- → Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine(2014)186 cited
- → IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas(2016)156 cited
- → The Tipping Point for Combination Therapy: Cancer Vaccines With Radiation, Chemotherapy, or Targeted Small Molecule Inhibitors(2012)145 cited
- → The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells(2016)142 cited
- → Immune Consequences of Tyrosine Kinase Inhibitors that Synergize with Cancer Immunotherapy(2015)109 cited
- → Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway(2014)73 cited
- → Radiation-induced survival responses promote immunogenic modulation to enhance immunotherapy in combinatorial regimens(2014)50 cited
- → The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic(2015)42 cited
- → Vaccine-Mediated Immunotherapy Directed against a Transcription Factor Driving the Metastatic Process(2014)36 cited
- → Attacking malignant cells that survive therapy(2013)33 cited